DONNA YU: Open Payments
NPI 1609380617 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,343 in 46 payments from 13 companies in 2025. Trend: 2023 $1,004 · 2024 $1,476 · 2025 $1,343
Food & beverage: $1,343
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $312 |
| Medtronic, Inc. | 2 | $189 |
| Amgen Inc. | 6 | $153 |
| AstraZeneca Pharmaceuticals LP | 8 | $149 |
| Exact Sciences Corporation | 5 | $123 |
| ABBVIE INC. | 4 | $110 |
| Novo Nordisk Inc | 3 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| Lilly USA, LLC | 2 | $52 |
| Insmed, Inc. | 2 | $49 |
Products named: SYMPLICITY G3, OTEZLA, Livdelzi, Cologuard Collection Kit, CREON, JARDIANCE, AIRSUPRA, Ozempic.
Industry payments across NY — which companies pay providers there.
